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Changes in renal function are usually found early in the course of diabetes
mellitus and include microscopic albuminuria (45-200 mg protein/24 h) (1),
polyuria (>4 liters/24 h), and an increase in glomerular filtration rate (GFR)'
(2). These early functional changes are unaccompanied by histological changes
and could well reflect the increase in plasma osmolality associated with diabetic
hyperglycemia (3). In 1983, Williams et al. (4) described the selective excretion
of glucosylated albumins by the mammalian kidney; i.e., the percent of nonen-
zymatically glucosylated (NEG) albumin in the urine of normal rats was signifi-
cantly higher than the percent of glucosylated albumin in plasma. We call this
preferential (urinary) excretion of glucosylated albumin "editing." In addition,
we use thephrase "editing ratio" to describe the ratioofthepercent glucosylation
of urine albumin to the percent glucosylation of plasma albumin. In 1984,
Ghiggeri et al. (5) also reported increased glucosylation of urinary albumin in
humans. Moreover, they observed a relative reduction ofediting in patients with
diabetes mellitus.
In the present study we further examine the process of editing as a function
of diabetes and age in both man and rat. We describe the actual time course for
the reduction ofediting after the onsetofchemically induced diabetes in the rat.
Furthermore, we offer a molecular/physiological explanation for the editing of
albumin populations by the normal nephron and suggest a pathophysiological
mechanism for the reduction ofediting found in diabetes . We also show that this
process is entirely reversible with insulin though not with the aldose reductase
inhibitor, Sorbinil. In addition, we distinguish the reduction of editing found in
diabetes from a more gradual decline ofediting that we find to accompany aging
in both man and rat.
This work wassupportedby National Institutes of Health grants AM-31602 and 5RO1HD15234, by
National Science Foundation grants PCM-8215938, and by General Clinical Research grant RR-
00997. A portion of this work waspresented at the 46th Annual Meeting of the American Diabetes
Association, Anaheim, CA,June 1986 .
'Abbreviations used in this paper:
￿
GFR, glomerular filtration rate; NEG, nonenzymatic glucosy-
lation; Stz, streptozotocin.
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Materials and Methods
Experimental Subjects.
￿
Human subjects without evidence of diabetes mellitus or hyper-
tension were identified among Los Alamos employees and their children. Males (n = 14)
ranged in age from 6 to 58 yr and females (n = 8) from 5 to 43 yr. The mean age of
control subjects was 33 ± 16. Diabetic subjects (Type 1) attended a summer camp organized
by the American Diabetes Association in New Mexico. Diabetic males (n = 13) ranged in
age from 10 to 24 yr, and females (n = 12), from 10 to 37 yr with a mean of 16 ± 9 (see
Table 1). None of the diabetic subjects were hypertensive . All human subjects provided a
casual urine, 1 ml of blood (heparinized), and informed consent (given by parents for
minors). There was no difference in editing ratio between a casual urine sample and a
24-h collection in two humans and six rats. In all studies of editing, a casual urine was
used. In human subjects, we evaluated the relationship between percent glucosylation of
plasma and percent glucosylation of urinary albumin as a function of either age or
diabetes.
In animal experiments, we used Sprague-Dawley, Fischer-344, or Wistar rats. We
induced chemical diabetes in Sprague-Dawley rats (6) and monitored the time course for
the reduction of editing of glucosylated albumin as a function of the kinetics of onset of
hyperglycemia . Fischer-344 rats served as a model (7) in which we studied age-related loss
of renal editing, also found in human subjects. In nondiabetic Wistar rats we studied the
effects of mannitol diuresis on GFR, urinary albumin content, and the status of editing.
Streptozotocin (Stz) and Sorbinil Administration.
￿
Male Sprague-Dawley rats (150-200 g)
received 50 mg i.p. of Stz per kilogram of body weight (6). Sorbinil (a gift from Dr. Nancy
Hutson, Pfizer, Groton, CT) was administered (20 mg/kg) by oral gavage (8). Animals
were kept in metabolic cages (Nalgene, Rochester, NY) for collection of 24-h urines. Tail
vein blood was used to measure plasma glucose, glucosylated albumin, and HbA IC.
Plasma glucose was measured spectrophotometrically (OD 650 nm) with toluidine (9).
Diabetes was also evaluated by quantitating the glucosylation of plasma albumin and
hemoglobin (10). Animals with plasma glucose concentrations >400 mg/dl, HbAIC values
>7%, and plasma albumin glycosylation values >2.8% were classified diabetic for this
study.
Separation of Glucosylated and Unmodified Albumin.
￿
Urines (3 ml) were exhaustively
dialyzed (4°C) against distilled water, lyophilized, and reconstituted in 250 Al of column
buffer (250 mM ammonium acetate containing 50 MM MgC12 and 0 .02% sodium azide,
pH 8.0). Heparinized blood was centrifuged and the plasma was exhaustively dialyzed
(4'C) against distilled water. Urine and plasma samples (0.05-0.5 mg protein) were added
to a (0.8 X 4 cm) Glycogel B (Pierce Chemical Co., Rockford, IL) column (11) in column
buffer. Nonglucosylated proteins were readily eluted with (20 ml) column buffer. Retained
glucosylated proteins were then eluted with 5 ml of 200 mM sorbitol in 50 mM Tris-HCI
(pH 8.5) for those albumin samples assayed by RIA (12). Alternatively, glucosylated
albumin was eluted with 200 mM citrate buffer (pH 4.5) for assay with bromocresol green
(10). Accuracy and reproducibility ofGlycogel B chromatography were tested by process-
ing known amounts of glucosylated or unmodified albumins or defined mixtures. We
recovered >99% of the protein applied to the column. In addition, the unbound fraction
contained no detectable glucosylated albumin and the bound fraction contained only
glucosylated albumin. The coefficient of variation (n = 6) for a given sample was <2% .
Quantilation ofAlbumin.
￿
Urine albumin was quantitated by RIA (12) with rabbit anti-
human albumin (12) and goat anti-y-globulin antisera (Boehringer Mannheim Diagnostics,
Inc., Houston, TX). With [1251]human serum albumin as standard, the RIA gave albumin
values that were linear from 12.5 to 250 ng, and indistinguishable values with both
glucosylated and unmodified albumins. Plasma albumin was quantitated by spectropho-
tometric measurement (OD, 630 nm) of the complex formed with bromocresol green
(10).
Determination ofthe Isoelectric Point (pI) ofGlucosylated Albumns.
￿
Fatty acid-free human
serum albumin (Sigma Chemical Co., St. Louis, MO) was glucosylated for 6 d (22°C) in
the presence of 100 mM glucose in PBS with 0 .02% sodium azide. Glucosylated andKOWLURU ET AL.
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TABLE I
Human Subjects
* Numbers in parentheses indicate mean age t SD.
unmodified albumins were separated on Glycogel B and dialyzed against distilled water
(4'C).
Plasma albumin from normal and diabetic rats was purified with Sepharose CL-6B (13).
SDS-PAGE (14) of these preparations gave a single band with an apparent M, of 68 X
103, which comigrated with native albumin. Glucosylated and unmodified albumins were
separated on Glycogel B, dialyzed, and their pIs were determined in acrylamide gels (6 X
130 mm) with pH 3-10 pharmalyte (Pharmacia Fine Chemicals, Piscataway, NJ) (15).
Renal Function.
￿
Clearance studies were carried out with minor modifications of a
published method (16). Wistar rats (200-300 g) were anesthetized (1 mg inactin/kg, i.p.)
and a jugular infusion catheter was inserted. All infusion solutions contained [sH]inulin
(8 uCi/ml). The ureter was ligated as it left the bladder, and a bladder cannula was
inserted for urine collection into preweighed tubes. Blood was collected from the cut tail
at the middle of each clearance period for determination of Na', K, and hematocrit.
Femoral vein blood was analyzed for percent glucosylation of plasma albumin and plasma
osmolality. Plasma and urine osmolalities were measured in a vapor pressure osmometer
(model 51000; Wescor Inc., Logan, UT).
2 h after the start ofa saline infusion (1 ml/h), baseline samples were collected. Because
of low urinary protein concentrations and flow rates in the premannitol infusion periods,
1 h collection periods were needed. At the end of two collections, infusion solutions were
switched to 5% mannitol in saline with an infusion rate of 5 ml/h. The duration of the
collection periods was subsequently reduced to 30 min . Additional 30-min collections
were made until a new, steady state was reached as indicated by two periods of equivalent
urine volume. In the mannitol infusion experiments GFR was calculated as inulin clearance
(17) and expressed as ml/min/kg body weight. In other experiments GFR was also
calculated as creatinine clearance (18). Plasma and 24-h urine creatinines were determined
spectrophotometrically by measuring OD at 500 nm with alkaline sodium picrate (19).
Urinary volume (ml) was estimated as the weight of the collected urine in grams.
Samples of blood were centrifuged and the plasma samples were separated. For all renal
studies, ['H] was quantitated by scintillation counting and GFR was calculated from the
count rates. Na` and K+ (in plasma and urine) were measured by flame photometry.
In other experiments, 2 h of mannitol infusions were followed by infusion of normal
saline. Additionalurine samples were collected at 30-min intervals to achieve a new steady-
state value. GFR, percent urinary glucosylated albumin, and diuresis were monitored as
above.
Results
Reduction of Renal Editing of Glucosylated Albumins in Patients with Diabetes
Mellitus. We found no significant differences in plasma and urinary creatinine
concentrations between normal and diabetic subjects, whose plasma creatinine
concentrations were <2 mg/dl (Table I). Our study of human diabetics was
confined to Type I diabetes. We observed an apparent reduction in the prefer-
Subject
category
n Age
Sex
(M/F)
Duration
of diabetes
Serum
creatinine
Urine
creatinine
yr yr ing/dl mg/dl
Nondiabetics 22 5-58 14:8 - 0.71 ± 0.41 114 ± 67
(33 f 15)*
Diabetics 25 10-37 13 :12 1-21 0.70 t 0.17 90 t 38
(16 t 9) (9 ± 7)1262
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FIGURE 1 . Reduction of the editing ratio in human
diabetes mellitus. Editing ratio in 10 controls (age range
10-35 yr) and 25 diabetics (age range 10-37 yr) was
calculated as describedin the text. The SEM is given for
both groups.
ential excretion ofglucosylated albumin in urine as evidenced by a >50% fall in
editing ratio (Fig. 1) in both sexes, varying in age from 10 to 37 yr. Our data
were in good agreement with data from groups A and B of Ghiggeri et al. (5),
in which all subjects had an albumin excretion rate <50 mg/24 h. We found a
strong inverse correlation between the fall in the percent urinary albumin
glucosylation (i,e., loss of editing) and the degree of microscopic albuminuria
(Fig. 2). The correlation coefficient (20) between loss ofediting and microscopic
albuminuria was -0.42 in our diabetic human subjects (p < 0.05). Data for 24-
h urine collections in Stz diabetic rats exhibited an even stronger (inverse)
correlation (r = -0 .89) between the level of microscopic albuminuria and the
reduction in editing ratio (please see below). There was no correlation between
the duration of diabetes and loss ofediting, during the first 10 yr of disease (r =
-0.127, n = 25). Beyond this point, the editing ratio is likely to be influenced
by both age and possibly the longer term renal effects of diabetes. We also note
a strong inverse correlation between the percentglucosylation ofplasma albumin
and the relative loss ofediting (Fig. 3).
Renal Editing in Diabetes: Editing Loss Correlates with the Development ofHyper-
glycemia. The phenomenon of editing is readily observed in the nondiabetic
150 g Sprague-Dawley rat (editing ratio = 15 ± 1, n = 8) and is markedly
reduced 3 wk after Stz induction of diabetes (editing ratio = 4 ± 0.8, n = 8).
Our studies ofhuman diabetics (and those ofGhiggeri et al. [5]) clearly demon-
strate a reduced level of editing associated with hyperglycemia. Such studies,
however, do not examine the rate at which editing is reduced in relation to the
onset of diabetes mellitus. We gave Stz to 150-g male Sprague-Dawley rats and
measured plasma glucose and editing levels daily. We observed a very rapidO
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FIGURE 2. Inverse correlation of editing ratio and microscopic albuminuria in diabetic
humans. The editing ratios (n = 25) were calculated and plotted against urinary albumin
concentrations (r = -0.42, p < 0.05).
reduction in editing after the injection of Stz which is virtually complete by day
three (Fig. 4). The kinetics of the decline in editing follow closely the develop-
ment ofhyperglycemia (Fig. 4) and also thedevelopment ofpolyuria, glucosuria,
and microscopic albuminuria but do not follow a more gradual increase in the
percent glucosylation ofplasma albumin (not shown).
Mechanism(s) ofLoss of Editing.
￿
We then evaluated a series of possible mech-
anisms to explain the loss ofediting observed in chemical diabetes mellitus. This
loss of editing does not result from Stz toxicity. The effect persists as long as
hyperglycemia persists, and well after the 24-h period when the signs of Stz
toxicity in liver (e.g., degranulation of rough endoplasmic reticulum, and mito-
chondria) swelling) (21, 22) have subsided. Occasionally, a Stz injected rat
(especially when the intraperitoneal injection route is used) will exhibit transient
hyperglycemia. We have studied such a rat (Fig. 5) and found that the transient
elevation in blood glucose is accompanied by a transient (and fully reversible)
reduction in editing. Moreover, in rats with fully established diabetes (>4 wk
duration) and a marked reduction in editing, the administration of insulin in
quantities sufficient to normalize plasma glucose levels (2 U of zinc prolamine
insulin perdiem, subcutaneously)was followed by restoration ofa normal editing
ratio by treatment day 9 (Fig. 6).
Possible Involvement of the Sorbitol Pathway.
￿
The polyol pathway is markedly
accelerated in poorly controlled diabetes (23). Increased rates of glucose reduc-1264
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FIGURE 3. Relationship between editing ratio and the percent glucosylation of plasma
albumin in man. Editing ratios were determined in control (n = 22) and diabetic (n = 25)
subjects and plotted against percent plasma albumin glucosylation. A different scale is used
for the percent plasma albumin glucosylation in normal and diabetic subjects.
tion by aldose reductase are associated with sorbitol accumulation and other
metabolic changes in red cells and lens (24). The polyol pathway has been
implicated in diabetic peripheral neuropathy (25) and cataract formation (26).
We have administered the aldose reductase inhibitorSorbinil concomitantly with
Stz injection and on a daily basis, thereafter. Sorbinil treated diabetic rats show
a reduction in editing which occurs with the same kinetics and to the same extent
as observed in animals treated with Stz alone (Fig. 4).
Mannitol Diuresis and Recovery Studies.
￿
We also studied the possible role of
osmotic diuresis by using mannitol infusion. Since mannitol is not a reducing
sugar (27), effects observed with mannitol cannot be attributed to rapid NEG of
protein amino groups. In the course ofmannitol induced diuresis in nondiabetic
Wistar rats (within 60-90 min after the initiation of mannitol infusion), we
observed (a) the expected increase in urine volume, (b) an increase in GFR, (c)
the appearance ofmicroscopic albuminuria, and (d) a markedreduction inediting
ratio (Fig. 7). We note that during mannitol diuresis there is a strong inverse
correlation (r = -0.44, n = 39, p <0.01) between loss ofediting and theobserved
increase in GFR (Fig. 8). The observed reduction in editing ratio with mannitol
infusion does not correlate with urine osmolality, urine or plasma Na' or K+, or
the hematocrit (data not shown) . Cessation ofthe mannitol infusion was followedD
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FIGURE 4.
￿
Kinetics of the reduction of editing after Stz injection; failure to prevent this
change with Sorbinil. The editing ratio for Stz-treated animals (n = 4) was determined at
different time intervalsafter Stz injection. The average editing ratioof six control rats before
inductionofdiabetes is shownas the closed square. Theediting ratioforStz-injected, Sorbinil-
treated rats (n = 4) is also shown at varying time intervals, after Stz injection. The average
plasma glucoselevels (A, A) arealso shown for both groups (n = 8).
by reversal of osmotic diuresis, normalization of GFR, and a concomitant
recovery of editing ratios to levels observed prior to infusion (Table 11).
Decline of the Editing Ratio with Aging.
￿
The preferential excretion ofglucosy-
lated albumin by the human kidney was initially studied in nondiabetic subjects
where we consistently observed editing ratios of 13-16 (ages 5-15 yr). The
average glucosylation ofurinary albumin in nondiabetic subjects between 10 and
15 yr ofage was 15% while the glucosylation ofplasma albumin in these subjects
was often <1%. The capacity of the human kidney to preferentially excrete
glucosylated albumin gradually diminished with age (Fig. 9 and Table 111). By
the sixth decade, editing ratios as low as five were observed. While age had a
marked effect upon editing ratios, gender did not significantly influence the
preferential renal excretion of glucosylated albumin. We found robust editing
in both young males and young females as well as an age-dependent (gradual)
decline ofediting in both sexes.1266
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Reductionandrecovery ofeditingratioafter
an Stz injection. These data were obtained in a rat that
developed transient hyperglycemia after Stz administra-
tion,and then recovered euglycemia in 10 d. The editing
ratios were plotted against percent plasma glucosylation.
(") Baseline value; (0) value at the height of hypergly-
cemia (5 d after injection of Stz); (0) recovery value (12
d afterinjection of Stz).
Decline of Editing in Aging was Unaccompanied by Microscopic Albuminuria.
￿
A
striking difference was observed between the reduction of editing found in
diabetes and that found with aging. The presence ofmicroscopic albuminuria is
a pathophysiological feature of the diabetic kidney (1) that correlates strongly
with the reduction ofediting found in diabetes (Fig. 2). However, in the absence
ofdiabetes, intrinsic renal disease, and any known systemic disease process, the
aging mammalian kidney exhibits a significant loss ofediting ratio in the absence
ofmicroscopic albuminuria (Table III). Thus, the pathophysiology and molecular
basis for the loss of editing are likely to be different in aging and diabetes
mellitus. The absolute values for the percent glucosylation of plasma and urine
albumin in normal subjects (at different ages) and diabetic subjects are given in
Table III. Examination of these data reveals that the reduction in editing ratio
in diabetes reflects the combined effects of an increase in the percent glucosyla-
tion of plasma albumin and a decrease in the percent glucosylation of urinary
albumin. In contrast, the decline in editing ratio in aging primarily reflects a
reduction in the percent glucosylation of urinary albumin since increases in
percent glucosylation ofplasma albumin are modest.
Decline of Editing in Aging in a Variety of Species.
￿
In the nondiabetic rat, the
magnitude of the editing ratio is a function of species and age. The 4-mo-old
Wistar rat exhibits the remarkable editing ratio of 35, the Fischer rat a ratio of
5, and the Sprague-Dawley rat is intermediate (Table IV). We also attempted to
identify an experimental system to study the reduction ofediting which appears
as a function ofaging in human populations. In the Fischer-344 rat, we found
that 3-mo-old males exhibit an editing ratio of 14, while in 24-mo-old male
Fischer-344 rats, the editing ratio has fallen below 5 (Table IV). In the rat, as in
man, this decline in editing which accompanies aging was not associated with
microscopic albuminuria (Fig. 10). It is interesting that the decline in editing
which develops gradually over a 50-yr period in humans appears to take place
on an accelerated schedule within the shorter lifespan ofthe Fischer-344 rat.KOWLURU ET AL.
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FIGURE 6.
￿
Recovery of physiological
editing ratio by Stz diabetic animals
after insulin treatment. Sprague-Daw-
ley rats (n = 4) with 4 wk of uncon-
trolled diabetes were injected daily
with 2 U of zinc protamine insulin
(subcutaneously). Editing ratios were
also calculated as were plasma glucose
and percent glucosylation of plasma
albumin. All were plotted against days
of insulin treatment.
Relationship Between GFR (24 h) Microscopic Albuminuria and Editing Ratios in
Aging and Diabetes. To further study the putative relationship between GFR,
microalbuminuria, and editing ratios, wemeasured GFR (as creatinine clearance)
in control and Stz diabetic rats and young (2 mo) and old (15 mo) Sprague-
Dawley rats (Fig. 10). In each ofthese animals we also measured the editing ratio
and the 24-h excretion of albumin in the urine. In Stz-diabetic animals, the
reduction in editing is associated with an increase in creatinine clearance and
microscopic albuminuria. On the other hand, the decrease in editing in aging is
associated with no significant change in GFR or microalbuminuria (Fig. 10).
Cationized Albumin.
￿
The term cationized albumin, is used by Ghiggeri and
coworkers (28, 29) to designate a class of albumin molecules which they found
in the plasma (but not in the urine) of fewer than half of all diabetics studied.
These albumin molecules bind to Con A-Sepharose suggesting glucosylation,
and yet they exhibit pIs that are more positive than 4.7, which is the pl ofnative
albumin. The chemical modification which produces cationized albumins is1268
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Effect of mannitol induced diuresis on GFRand
editing ratioof nondiabetic Wistar rats. Nondiabetic Wistar
rats were anesthetized with Inactin and infused with a solu-
tion of mannitol. Timed samples of urine and blood were
collected and urine volume, GFR, editing ratio, osmolality,
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unknown. They do not appear to contribute directly to the phenomenon of
editing since they do not appear in human urine (28). Moreover, we have found
that these materials are not simply a result of NEG of albumin, a process that
consistently yields protein with pIs below 4.7 (Fig. 11). These values reflect the
fact that for each molecule of glucose attached to albumin there is a loss of a
single positive change at physiological plasma pH. We have not found cationized
albumins in the plasma ofour diabetic rats, all ofwhom lose editing in a striking
way. In addition, in the study ofGhiggeri et al. (28) no correlation is attempted
between the attenuation ofediting and the presence of cationized albumins.
Discussion
The data presented demonstrate that glucosylated albumin is selectively ex-
creted by the normal mammalian kidney. The selective editing of albumin
populations declines very gradually (over a 50-yr period) with age and veryZ
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Reversal ofReduction ofEditing after Recovery
from Mannitol Diuresis
FIGURE 8. Correlation between GFR and
percent glucosylation of urinary albumin dur-
ing mannitol diuresis in nondiabetic Wistar
rats. Data were obtained at each of thedifferent
times during the mannitol diuresis and GFR
and editing ratios were compared at each time
for seven animals. There was a strong inverse
correlation between these parameters with an
rvalueof -0.44 (n = 39).
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rapidly (with kinetics that follow the onset of hyperglycemia) in diabetes. Para-
doxically, although the percent glucosylation of plasma albumin is increased by
about fivefold in diabetes mellitus, there is a concomitant and marked reduction
in the percent glucosylation ofurinary albumin. Thus, it is not possible to explain
the microscopic albuminuria observed in diabetes mellitus in terms of an exag-
geration of the selective excretion of glucosylated albumin normally found in
the absence of diabetes. Conversely, we suggest that the loss ofediting in diabetes
is a dilutional consequence of microscopic albuminuria (see below).
The molecular mechanisms that promote this reduction in editing are clearly
different in diabetes and aging. The rapid reduction of editing that follows the
Condition Editing ratio
urine/plasma
GFR
(ml/min/kg
body weight)
Baseline saline infusion 34.0 1.93
Mannitol diuresis 20.5 5.23
Recovery from mannitol diuresis 32.5 1.061270
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Decline in editingas a function of age
in human subjects. Percent glucosylation of both
plasma and urinary albumin was measured for
individuals ranging in age between 5 and 58 yr.
onset of diabetes is invariably accompanied by microscopic albuminuria and a
conspicuous increase in GFR, while these factors are absent in the decline of
editing that appears as a function of age. Our data suggest a model for the
reduction ofediting in diabetes that is based on the phenomenon of microscopic
albuminuria as well as our experiments with mannitol diuresis. The infusion of
mannitol into thejugular vein ofthenondiabetic male Wistar rat reliably induces
an increase in GFR, microscopic albuminuria, and loss ofediting (see below).
The first report of the selective excretion of glucosylated albumin by the
mammalian kidney appeared in 1983 and focused upon the Sprague-Dawley rat
(4). Morerecently, Ghiggeri andcoworkershavedescribedtheselective excretion
ofglucosylated albumin in normal individuals and a reduction ofthis capability
in diabetes (5). We note here that loss ofediting thus far, is observed in patients
with Type I diabetes mellitus. Loss of editing appears to be a consequence of
hyperglycemia and especially the increase in GFR which accompanies hypergly-
cemia. However, studies in Type II patients will be needed to confirm this
expectation.
We believe that the proposal of Ghiggeri et al. (5) that the phenomenon of
editing is best explained in terms ofpreferential glomerular filtration of gluco-
sylated albumin is untenable. Glucosylated albumins found in the urine had an
even lower pl (hence more negative charge) than native albumin at the pH of
the glomerular filtrate (7.4). Thus the glomerular filtration apparatus with its
negatively charged podocytes heavily endowed with sialated podocalyxin (30)
should be less permeable to glucosylated than unmodified albumins. Ghiggeri et
al. have, in addition, suggested that the attenuation in editing of glucosylatedKOWLURU ET AL.
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TABLE III
A Listing of the Individual Valuesfor Plasma (g/dl) and Urine (,ug'/dl)Albumin Levels
Illustrating OurFindingsforBoth Nondiabetic and Diabetic Human Subjects
Plasma albumin
￿
Urinary albumin
Subjects Age
￿
Glucosy- Glucosy- Total Glucosy- Glucosyla- Editing Total lated lation
￿
laced tion ratio
yr g/dl g/dl % pg/dl pg/dl
Nondiabetic
1
￿
6 ND ND ND 621 103 16.6 ND
2
￿
10 4.6 0.050 1.08 190 27 14.1 13.0
3
￿
15 ND ND ND 320 50 15.6 ND
4
￿
18 4.3 0.040 0.93 280 36 12.8 13.7
5 27 4.2 0.033 0.78 328 37 11.3 14.5
6 29 4.8 0.048 1.00 322 32 9.9 9.9
7
￿
29 4.7 0.061 1.29 625 69 11 .0 8.5
8
￿
31 4.3 0.033 0.77 993 109 10.9 14.1
9
￿
31 4.2 0.045 1.07 205 32 15.6 14.5
10
￿
31 3.9 0.054 1.38 112 14 12 .5 9.0
11
￿
31 4.6 0.041 0.89 559 63 11 .3 12.6
12 32 4.5 0.054 1.20 445 57 12.8 10.6
13 52 4.6 0.032 0.69 392 25 6.4 9.2
14
￿
53 4.3 0.034 0.79 329 17 5.1 6.4
Diabetic
1
￿
10 4.8 0.14 2.9 1,345 21 1.56 0.53
2
￿
11 4.5 0.31 6.9 945 49 5.18 0.75
3
￿
11 5.1 0.34 6.6 945 49 5.18 0.78
4
￿
11 4.9 0.25 5.1 661 36 5.44 1.06
5
￿
12 5.5 0.31 5.6 2,139 96 4.48 0.80
6
￿
13 5.0 0.09 1.8 1,965 22 1.12 0.62
7
￿
13 5.2 0.17 3.2 470 40 2.03 0.63
8
￿
14 4.5 0.24 5.3 3,987 56 1.40 0.26
9
￿
17 4.9 0.11 2.2 3,665 55 1.50 0.68
10
￿
18 5.6 0.35 6.2 1,635 34 2.08 0.33
11
￿
24 4.9 0.10 2.0 1,170 41 3.50 1.75
12 24 4.1 0.09 2.2 2,065 155 7.50 3.40
13 29 5.0 0.34 6.8 670 23 3.43 0.50
14
￿
31 5.7 0.37 6.5 1,230 36 2.92 0.45
Significance (p values) for age vs. percent plasma albumin glucosylation: r = -0.39; n = 12, p =
> 0.05, notsignificant; age vs. percent urine albumin glucosylation: r = -0.86, n = 14, p < 0.001 ;
agevs. editing ratio: r = -0.623, n = 12, p <0.05.
albumin in diabetes is explained by a reduction in the filtration of glucosylated
albumin. We must disagree with this model for the following reasons:
If the site of editing were in fact the glomerulus, then editing should be
strongly enhanced in diabetes rather than diminished, since the amount of
glucosylated albumin presented to the glomerulus is increased by a factor of 4-
5. Furthermore, ifthe locus of editing were the glomerulus, and editing repre-
sented a preferential filtration ofglucosylated albumin that somehow is reduced
in diabetes, then the absolute quantity of glucosylated albumin that is excreted
in diabetes should also diminish. In fact, the total glucosylated albumin in the
urine is markedly increased (51.6 ± 3 Ag/24 h in four diabetic rats vs. 12.3 ±1272
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Data are mean and standard error for
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1 .6 ug/24 h in four control rats) even though the percent glucosylation of urine
albumin and the editing ratios are, in fact, markedly diminished in the diabetic
animals . We note that the increased filtration of unmodified (pl 4.7) and
glucosylated albumin (pl 4.5) in diabetes mellitus could also be due to net
decrease in the negative charge of the filtration apparatus . Significant reduction
Species Age Editing Ratio
Sprague-Dawley Rat 1 mo 18
3 mo 16
12 mo 15
Fischer-344 3 mo 14
2 yr <5
Wistar 4 mo 35
Human 5-10 yr 14-16KOWLURU ET AL.
￿
127 3
FIGURE 11 .
￿
Determination of isoelectric point for glucosylated hu-
man serumalbumin . Data represent the relative mobilities ofboth (in
vitro) glucosylated (A) andunmodified (B)humanserumalbumin . The
apparent p1s of unmodified and glucosylated albumins were deter-
mined by extrapolating their observed electrophoretic mobilities onto
a "standard curve" using calibration proteins with known pls . The
standards used were : amyloglucosidase (3.5), soybean trypsin inhibitor
(4.55), ,B-lactoglobulin A (5.20), bovine carbonic anhydrase B (5.85),
human carbonic anhydrase B (6.55), horse myoglobin (6.85, 7.35),
lentil lectin (8.15, 8.45, 8.65) andbovine pancreas trypsinogen (9.30) .
in glomerular sialic acid (31) and glycosaminoglycan (32, 33) content is found in
diabetic animals .
As an alternative explanation of reduced editing based on filtration mecha-
nisms, we turn to the striking increases in microalbuminuria and GFR which are
well documented in the human diabetic (1, 2) . It is clear that associated with
these increases there is a corresponding increase in the delivery of unmodified
albumin into the proximal tubule . Moreover, micropuncture studies indicate
that the proximal tubule normally reabsorbs almost all ofthe unmodified albumin
presented to it (34) . We suggest that it is the proximal tubule that is the site of
editing and that selectively excludes glucosylated albumin from the process of
reabsorption .
In this view the proposed failure of the proximal tubule to reabsorb glucosy-
lated albumin might reflect a change in the local surface charge of albumin (35)
since each attached glucose molecule neutralizes a positive charge associated with
lysine or the NH2-terminal (36) . This idea is indirectly supported by the obser-
vation that the net charge of proteins plays a contributing role in their reabsorp-
tion by the proximal tubule . Chemically increasing the positive charge for a given
macromolecule increases the extent of its reabsorption (37) . Alternatively, the
glucosylation of albumin could obfuscate its recognition by specific albumin
binding sites on the luminal surface of proximal tubular epithelial cells . Such
binding sites might depend upon the recognition of one or more lysine groups
that are modified by NEG and/or a specific albumin conformer that is lost as a
consequence of NEG, or some combination of the above . We suggest that it is
the proximal tubule that, in diabetes, is overwhelmed by the influx of albumin,
i.e ., its maximal reabsorptive capacity is exceeded (38) .1274
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In this scenario, the diabetic nephron allows an increased amount of unmodi-
fied albumin to escape into the urine and to dilute the glucosylated albumin
which is simply not reabsorbed either in normal or diabetic individuals. This
relative dilution by unmodified albumin is the cause of the apparent loss of
editing. This apparent reduction ofediting does not appear because glucosylated
albuminis not beingfiltered by the diabetic glomerulus. Rather, it isseen because
unmodified albumin is now appearing in the glomerular filtrate in larger than
normal amounts. Thus, two consequences of increased renal plasma flow and
increased GFR appear in the diabetic nephron. These are the appearance of
microscopicalbuminuria and a concomitant reduction in editing ratio. These are
acute consequences ofthe diabetic state and are rapidly reversible when blood
glucose levels are normalized by insulin (Fig. 6). In addition, reduction ofediting
was also seen to be reversible in threeother examples encountered in this study.
One of our control human subjects exhibited an attenuated editing ratio of5, at
3 mo after the delivery of a normal infant. This subject recovered an editing
ratio of 14 at 7 mo postpartum . There was no evidence of maternal hypergly-
cemia at any time during or after this pregnancy. We also observed reversible
attenuation in editing in a Stz-diabetic animal with transient hyperglycemia (Fig.
5). Finally, the mannitol diuresis experiments in nondiabetic Wistar rats also
demonstrated a rapidly reversible reduction in editing (Table II). These acute
changes are quite different (in temporal character and reversibility) from the
chronic changes suggested by Brenner et al. (39) (gradual long-term destruction
of the glomerulus) to be associated with an increase in GFR, and possibly
increased deposition of protein in the mesangium.
We note that some of our diabetic patients are old enough to encounter age-
related declines in editing ratio. In each of these patients (18-34 yr of age),
however, the editing ratio was without exception (1.3 ± 1.1, n = 6) much more
reduced than in their age-matched (nondiabetic) counterparts (11 .8 ± 1.8, n =
6). Moreover, when we compared our diabetics of<5 yr duration with those of
>15 yr duration, we foundexamples ofboth moderate and severe editingdeclines
in each of the groups. As indicated above, the severity of the decline in editing
correlated with the severity and not the duration of diabetes. These and our
other findings support the concept that the editing changes are a manifestation
ofthe increased GFR andmicroalbuminuria rather than changes which gradually
occur over many years ofdiabetes. Clearly, a rapid and marked decline in editing
(which is fully reversible) can be observed within days of the induction of Stz
diabetes in our murine subjects.
It is important to note that as a consequence of NEG, a significant amount of
protein refolding can occur (40). We have observed striking changes in the
polymerization capacity of tubulin (41), and in the function of calmodulin with
respect to activation of its target enzymes and its binding of Ca21 (42) all as a
consequence of NEG. Analogous changes in the folding of albumin as a conse-
quence of NEG may occur as evidenced by changes in the way it is recognized
by different cells. Endothelial cells avidly micropinocytose NEG albumin and
rigorously exclude unmodified albumin (43). Vlassara et al. (44) have observed
that glucosylated myelin basic protein was preferentially ingested by peritoneal
macrophages. In contrast, pulmonary macrophages ingest unmodified albuminKOWLURU ET AL.
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more rapidly that NEG albumin (45). The data presented here strongly suggest
that the proximal tubular epithelium avidly reabsorbs unmodified albumin and
rigorously excludes NEG albumin. When taken together these data support the
hypothesis that NEG can change folding and/or function and/or the recognition
of proteins.
In the case of plasma albumin, there appears a consistent theme of retaining
unmodified albumin within the vascular compartment and rapidly expelling
NEG albumin from the circulation. This is also seen from the fact that while
unmodified albumin has a half-life of >2 wk (46, 47), after insulin therapy
elevations in glucosylated albumin disappear within 6 d (Fig. 6). Clearly, the
escape of NEG albumin from the systemic circulation is far more rapid than the
clearance or turnover of unmodified albumin which is estimated at 17-19 d (46,
47). Our data are in agreement with that of Morris and Preddy (48) who found
a circulating half-life of 125I-glucosylated albumin of ^-6 d in alloxan diabetic
dogs. In contrast, Day et al. (49) report a 48 h half life for [' 251] glucosylated
albumin in diabetic rats. These studies also find the surprising half-life of 48 h
for nonglucosylated 1251-albumin. However, Garlick and Mazer (46) published
an estimate of 17 d for the half-life of human serum albumin. We believe that
our experimental approach is both accurate and reliable because we have
measured the kinetics of disappearance of endogenously formed unlabeled
glucosylated albumin by sensitive RIA. Introduction of
1251 into exogenous
albumin carries the risk of loss and/or exchange of label and/or accelerated
removal of the labeled protein from the circulation. Our finding of rapid
disappearance of glucosylated albumin from the circulation is consistent with
increased rates of deposition of albumin in the basement membrane of the
diabetic capillary (50, 51) and consistent with the findings of Williams et al. (43)
of increased micropinocytic ingestion of glucosylated albumin by endothelium.
The mannitol infusion experiments provide an independent way of producing
an increase in GFR, presumably in association with the plasma volume expansion
that follows infusion of hypertonic solutions. The mannitol associated reduction
in editing is principally correlated with the increase in plasma osmolality, GFR,
and the associated microalbuminuria.
Our model for editing and its loss in diabetes is thus supported by the following
ideas and/or observations: (a) The increase in GFR in diabetes presents an
increased amount (two- to threefold) of albumin to the proximal tubule; (b) since
^"90% of filtered albumin is normally reabsorbed (52) (i.e., the tubule is working
near saturation), it seems reasonable to suggest that increased albumin presented
in diabetes or mannitol diuresis exceeds the maximal reabsorptive capacity of
the tubule. This provides a simple explanation for the microalbuminuria of early
diabetes; (c) the total amount of glucosylated albumin per 24 h was actually
increased in the urine of our diabetic rats, when the editing ratio was attenuated.
This is also seen in human diabetics in the data of Ghiggeri et al . (5), especially
in groups A and B. This relationship is obfuscated in group C, presumably
because of the increased age of the subjects; (d) in mannitol diuresis, loss of
editing appears with the same kinetics as microalbuminuria; (e) we consistently
observe an inverse relationship between the editing ratio and microalbuminuria.
The gradual decline of editing with age is clearly different than the rapid1276
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reduction in diabetes, since in the normal aging kidney, no albuminuria is seen
to accompany the loss of editing (Fig. 10). Moreover, GFR tends to diminish
with age (Fig. 10 and reference 53) in contrast to the increase in GFR in early
diabetes and with mannitol diuresis. While the fall in editing ratio in aging is
primarily associated with a decrease in percent glucosylation of urine albumin,
in diabetes mellitus the reduction in editing ratio is associated with both an
increase in the percent plasma albumin glucosylation and a decrease in urinary
albumin glucosylation.
In conclusion, the data presented here strongly suggest that the reduction in
editing ratio in diabetes is a reversible phenomenon and primarily results from
the differential handling of unmodified and glucosylated albumins by the prox-
imal tubule, and the inability of the proximal tubule to reabsorb the increased
amounts of unmodified albumin presented to it in diabetes. Definitive proof of
this model must await micropuncture study of the fate of glucosylated and
unmodified albumin in the proximal tubule. Our data also suggest that the
microalbuminuria of early diabetes is a feature of the (reversible) increase in
GFR and inability of the proximal tubule to effectively reabsorb the increased
quantities of albumin which are filtered.
Summary
In previous studies in the Sprague-Dawley rat, Williams and coworkers (4)
reported the phenomenon ofselective urinary excretion ofglucosylated albumin
(editing, i.e., the percent glucosylation of urinary albumin is more than that of
plasma albumin) by the mammalian kidney. Ghiggeri and coworkers (5) subse-
quentlyfound that the extent ofeditingis reduced in human diabetics. Moreover,
the reduction in editing in diabetes correlates inversely with levels of microal-
buminuria. We also find reduction in the extent of editing in diabetic humans.
We find a striking inverse correlation not only with the magnitude of microal-
buminuria but also with the extent ofplasma albumin glucosylation. In contrast,
we found little correlation between the reduction in editing and the duration of
diabetes in human subjects. Stz induced diabetes in the Sprague-Dawley rat is
associated with a striking and rapid reduction in editing which develops virtually
with the same kinetics exhibited by the appearance of hyperglycemia. This loss
ofediting is rapidly reversed by daily administration ofinsulin but not by aldose
reductase inhibitors.
Mannitol infusion in anesthetized Wistar rats resulted in an increase in urine
volume, GFR, and microalbuminuria, and was also accompanied by a marked
reduction in editing. This reduction was rapidly reversed by a cessation of
mannitol infusion. We propose here that glucosylated albumin (in contrast to
unmodified albumin) is not reabsorbed by the proximal tubule, and thus, is
preferentially excreted in the urine. We postulate that the increase in GFR which
emerges as a consequence of increased plasma osmolality in diabetes mellitus
delivers more albumin to the proximal tubule than can be reabsorbed. This
results in a dilution of excreted glucosylated albumin molecules by excreted
unmodified albumin, which appears as the early microscopic albuminuria of
diabetes. Paradoxically, the fallin apparent editing isaccompanied by an absolute
increase in the total quantity of glucosylated albumin excreted.KOWLURU ET AL.
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In contrast, we found that editing of glucosylated albumin by the normal
kidney is found to gradually decline as a function of age without the appearance
of microalbuminuria. This suggests that a different mechanism operates to
produce the loss of editing seen with aging in man, and as clearly (but in a
shorter absolute time intervals) in the Fischer-344 rat.
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